Supplementary Table 1

Published: 20 July 2019| Version 1 | DOI: 10.17632/5p3drcd262.1
Gregory Delost,
Rachel Giesey,
Luisa Christensen,
Jeffrey Scott,
Kevin Cooper


Mycosis fungoides patient- and physician-reported outcomes in the total cohort, AYA, and adults. Results by specific treatment are also shown (n=0 for AYA topical targretin and oral targretin). Some patients received multiple treatment types. *= statistically significant between adults versus AYA by Chi-Squared analysis at p<0.05. **= statistically significant reduction in itch by unpaired t-test at p<0.05.